Overview
- 2 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-04-22.
At a glance
Inspections
2
Form 483s
2
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 14 Apr 2025 – 22 Apr 2025 | Human Drugs | 483 | On file |
| 22 Aug 2022 – 30 Aug 2022 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
30 Aug 2022
21 CFR 211.160(a)
Deviations from laboratory control requirements
Cited by Kham Phommachanh, Rita K Kabaso
30 Aug 2022
21 CFR 211.170(b)
Reserve samples identified, representative, stored
Cited by Kham Phommachanh, Rita K Kabaso
30 Aug 2022
21 CFR 211.25(a)
Training--operations, GMPs, written procedures
Cited by Kham Phommachanh, Rita K Kabaso
30 Aug 2022
21 CFR 211.52
Washing and toilet facilities are deficient
Cited by Kham Phommachanh, Rita K Kabaso
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.52 | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind TTY Biopharm Company Limited Lioudu Factory's 2 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat